Matrix Private Capital Group’s iShares Biotechnology ETF IBB Stock Holding History

Matrix Private Capital Group’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$67.5K	Hold	400	–	–	0.03%	110
2025 Q4	$67.5K	Hold	400	–	–	0.03%	112
2025 Q3	$57.7K	Hold	400	–	–	0.03%	110
2025 Q2	$50.6K	Hold	400	–	–	0.03%	113
2025 Q1	$51.2K	Hold	400	–	–	0.03%	118
2024 Q4	$52.9K	Hold	400	–	–	0.03%	129
2024 Q3	$58.2K	Hold	400	–	–	0.03%	129
2024 Q2	$54.9K	Hold	400	–	–	0.03%	129
2024 Q1	$54.9K	Hold	400	–	–	0.04%	124
2023 Q4	$54.3K	Hold	400	–	–	0.04%	121
2023 Q3	$49K	Hold	400	–	–	0.04%	135
2023 Q2	$50.8K	Hold	400	–	–	0.04%	138
2023 Q1	$51.7K	Buy	+400	New	+$52.4K	0.04%	156

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Matrix Private Capital Group's IBB Position: Q1 2026 in Review

Matrix Private Capital Group held its iShares Biotechnology ETF (IBB) position steady in Q1 2026 at 400 shares worth $67.5K. The position accounts for 0.03% of the portfolio, ranked #110.

Matrix Private Capital Group first reported a position in IBB in Q1 2023 and has held it in 13 quarters since. 919 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

Matrix Private Capital Group held 400 shares of iShares Biotechnology ETF worth $67.5K as of Q1 2026.
Matrix Private Capital Group left its iShares Biotechnology ETF share count unchanged in Q1 2026.
iShares Biotechnology ETF made up 0.03% of Matrix Private Capital Group's portfolio in Q1 2026, its #110 holding.
Matrix Private Capital Group first reported a position in iShares Biotechnology ETF in Q1 2023 and has held it in 13 quarters since.
919 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Matrix Private Capital Group's 13F filing for Q1 2026, filed 15 May 2026.